| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 405.45B | 381.66B | 363.37B | 338.83B | 302.75B | 275.18B |
| Gross Profit | 81.45B | 71.65B | 59.95B | 46.36B | 41.40B | 36.85B |
| EBITDA | 50.25B | 41.07B | 30.07B | 19.61B | 18.90B | 16.68B |
| Net Income | 34.56B | 27.63B | 19.61B | 12.23B | 11.54B | 10.12B |
Balance Sheet | ||||||
| Total Assets | 301.08B | 334.95B | 340.11B | 313.39B | 300.74B | 271.15B |
| Cash, Cash Equivalents and Short-Term Investments | 37.29B | 47.65B | 53.30B | 72.32B | 56.96B | 64.13B |
| Total Debt | 24.43B | 38.56B | 39.59B | 30.50B | 33.70B | 30.71B |
| Total Liabilities | 119.96B | 150.66B | 172.87B | 166.22B | 163.84B | 135.29B |
| Stockholders Equity | 177.69B | 180.67B | 164.36B | 142.47B | 132.90B | 132.14B |
Cash Flow | ||||||
| Free Cash Flow | -9.03B | 1.55B | -16.45B | 20.78B | -1.82B | 17.93B |
| Operating Cash Flow | -5.80B | 5.88B | -13.10B | 25.83B | 1.19B | 22.57B |
| Investing Cash Flow | 745.00M | -1.41B | -8.10B | -5.43B | 1.04B | -324.00M |
| Financing Cash Flow | 10.48B | -12.71B | -491.00M | -8.32B | -8.01B | 3.64B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | ¥643.72B | 13.13 | ― | 2.13% | 15.98% | 82.99% | |
76 Outperform | ¥221.44B | 14.34 | 8.53% | 2.45% | 5.14% | -10.92% | |
67 Neutral | ¥910.80B | 9.02 | 0.85% | 2.36% | -0.03% | -89.02% | |
67 Neutral | ¥105.76B | 27.14 | 2.57% | 3.57% | 2.69% | 1.74% | |
66 Neutral | ¥6.04T | 42.68 | 9.46% | 1.52% | 1.60% | 5.80% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
52 Neutral | ¥479.49B | 16.11 | 1.44% | 4.80% | 0.68% | ― |